Halley E. Gilbert - 13 Jun 2023 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Reporting relationship: Director
Issuer ticker: PCVX
Reported as of: 13 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jun 2023, 17:52:46 UTC
Prior SEC filing: 02 Jun 2023
Next SEC filing: 16 Jun 2023
Source filing: View source filing
Reporting owner signature: Halley E. Gilbert, by /s/ Ron A. Metzger, Attorney-in-Fact

Key filing fact

Halley E. Gilbert filed Form 4 for Vaxcyte, Inc. (PCVX) on 15 Jun 2023.

Key facts

This page summarizes Halley E. Gilbert's Form 4 filing for Vaxcyte, Inc. (PCVX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 15 Jun 2023, 17:52.

Change

Previous filing in this sequence was filed on 02 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PCVX transaction

Common Stock

Award

Transaction value: $0
Shares: +2,500
Change %: +80%
Price: $0.000000
Shares after: 5,625
Date: 13 Jun 2023
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PCVX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +15,000
Change %
Price: $0.000000
Shares after: 15,000
Date: 13 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $53.08
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Footnote F2

The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.